Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
0.2730
-0.0030 (-1.09%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Scinai Immunotherapeutics Market Cap
Scinai Immunotherapeutics has a market cap or net worth of $1.08 million as of August 3, 2026. Its market cap has decreased by -28.09% in one year.
Market Cap
1.08M
Enterprise Value
1.61M
1-Year Change
-28.09%
Ranking
Category
Stock Price
$0.27
ChartMarket Cap Chart
Since May 12, 2015, Scinai Immunotherapeutics's market cap has decreased from $5.42M to $1.08M, a decrease of -80.04%. That is a compound annual growth rate of -13.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.08M | -56.23% |
| Dec 31, 2025 | 2.47M | -13.44% |
| Dec 31, 2024 | 2.85M | 10.12% |
| Dec 29, 2023 | 2.59M | -74.89% |
| Dec 30, 2022 | 10.32M | -76.24% |
| Dec 31, 2021 | 43.42M | 34.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moleculin Biotech | 2.13M |
| Virax Biolabs Group | 2.09M |
| Calidi Biotherapeutics | 1.99M |
| Matinas BioPharma Holdings | 1.88M |
| CDT Equity | 1.85M |
| Bone Biologics | 1.52M |
| VivoSim Labs | 1.20M |
| Biodexa Pharmaceuticals | 1.09M |